🇺🇸 FDA
Patent

US 11173173

Methods for treating chemoresistant cancer-initiating cells

granted A61KA61K31/136A61K31/18

Quick answer

US patent 11173173 (Methods for treating chemoresistant cancer-initiating cells) held by UNIVERSITY OF CONNECTICUT expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/136, A61K31/18, A61K31/337, A61K31/4745